Table 1. Basic characteristics of included studies.
| First author | Year | Time to collect cases (year) | Country | Antibodies | NCM | CIN | CC tissue | Evaluation index | NOS | Reference | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SCC | AC | ||||||||||
| Cao | 2010 | 2006–2007 | China | Santa Cruz | 12 | NA | 22 | 8 | a | 7 | [20] |
| Zhao | 2011 | 2005–2010 | China | Santa Cruz | 10 | 20 | 30 | NA | a, b, c | 7 | [21] |
| Deng | 2012 | 2009–2010 | China | Bioss Antibodies | 9 | NA | NA | 46 | a, b | 7 | [22] |
| Wan | 2012 | 2010–2011 | China | Epitomics | 10 | 30 | 35 | 5 | a, b | 7 | [23] |
| Huang | 2013 | 2011–2012 | China | Dongsheng Biotech Co. Ltd | 20 | 30 | 14 | 6 | a, b | 7 | [24] |
| Zhang | 2013 | 2008–2012 | China | Cell Signaling | 28 | NA | 10 | 42 | a, b | 7 | [25] |
| Tang | 2013 | 2010–2012 | China | Santa Cruz | 10 | 30 | 16 | 4 | a, b | 7 | [26] |
| Yan | 2015 | 2005–2014 | China | Fuzhou Maixin Biotech. Co. Ltd | NA | 55 | NA | 66 | b, c | 7 | [27] |
| Liu | 2015 | 2008–2010 | China | Abcam | 20 | NA | 42 | 10 | a, b | 7 | [28] |
| Jing | 2014 | 2011–2012 | China | Santa Cruz | 28 | NA | NA | 43 | a, b, c | 8 | [29] |
a, The expression of OCT-4 in normal cervical tissues and CC tissues. b, OCT-4 expression in cervical tissues with different degrees of differentiation. c, OCT-4 expression in CC of different lymphatic metastases.
Abbreviations: AC, adenocarcinoma; NA, not available; NCE, normal cervical tissue; SCC, squamous cell carcinoma.